“Chemical Analogues” of HLA-DM Can Induce a Peptide-receptive State in HLA-DR Molecules*
暂无分享,去创建一个
[1] P. Cresswell,et al. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.
[2] R. Doebele,et al. Determination of the HLA-DM interaction site on HLA-DR molecules. , 2000, Immunity.
[3] P. Cresswell,et al. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.
[4] D. Wiley,et al. MHC class II function preserved by low-affinity peptide interactions preceding stable binding , 1994, Nature.
[5] O. Bakke,et al. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.
[6] D. Zaller,et al. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. , 1998, Immunity.
[7] D. Wiley,et al. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide , 1992, Cell.
[8] L. Stern,et al. A three-step kinetic mechanism for peptide binding to MHC class II proteins. , 2000, Biochemistry.
[9] L. Stern,et al. The kinetic basis of peptide exchange catalysis by HLA-DM , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] G. Hämmerling,et al. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] G. Hämmerling,et al. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Mcconnell,et al. Peptide Binding to Active Class II MHC Protein on the Cell Surface1 , 2001, The Journal of Immunology.
[13] P. Cresswell,et al. HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules , 1996, The Journal of experimental medicine.
[14] L Gauthier,et al. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Woody,et al. Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin , 1982, Nature.
[16] A. Sant,et al. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. , 1999, Journal of immunology.
[17] J. Strominger,et al. A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Woods,et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. , 1998, Journal of immunology.
[19] G. Hämmerling,et al. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. , 1997, Immunity.
[20] Lawrence Steinman,et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.
[21] S. Sadegh-Nasseri,et al. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. , 1999, Journal of immunology.
[22] O. Rötzschke,et al. Small-molecular compounds enhance the loading of APC with encephalitogenic MBP protein. , 2003, Journal of autoimmunity.
[23] R. Sékaly,et al. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. , 1996, The EMBO journal.
[24] B. Evavold,et al. Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.
[25] D. Zaller,et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.
[26] L. Stern,et al. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. , 1999, Journal of immunology.
[27] C. Brosnan,et al. Induction and Suppression of an Autoimmune Disease by Oligomerized T Cell Epitopes , 2000, The Journal of experimental medicine.
[28] J. Strominger,et al. Ligand Exchange of Major Histocompatibility Complex Class II Proteins Is Triggered by H-bond Donor Groups of Small Molecules* , 2002, The Journal of Biological Chemistry.
[29] M. Vrljic,et al. Formation of a highly peptide-receptive state of class II MHC. , 1998, Immunity.
[30] G. Nolan,et al. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. , 2003, Immunity.
[31] D. Zaller,et al. Identification of the Lateral Interaction Surfaces of Human Histocompatibility Leukocyte Antigen (HLA)-DM with HLA-DR1 by Formation of Tethered Complexes That Present Enhanced HLA-DM Catalysis , 2002, Journal of Experimental Medicine.